Infinity Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Infinity Pharmaceuticals Inc.
Vanguard Total Stock Market Index Fund
1,298,402
2.27%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
724,616
1.27%
0
0%
07/31/2018
Biotech Growth Trust Plc (The)
433,767
0.76%
-203,459
0.14%
09/30/2017
Bridgeway Ultra Small Company Market Fund
350,000
0.62%
0
0.18%
12/31/2017
Wasatch Ultra Growth Fund
282,361
0.5%
282,361
0.34%
03/31/2018
Fidelity Spartan Extended Market Index Fund
236,483
0.42%
0
0%
07/31/2018
FCP OP Medical BioHe@lth-Trends
204,286
0.36%
23,000
0.26%
11/30/2017
DFA US Small Cap Portfolio
180,437
0.32%
95,077
0%
04/30/2018
British Columbia Inv Management Corp.
163,190
0.28%
163,190
0%
03/31/2017
DFA US Core Equity 2 Portfolio
127,833
0.23%
0
0%
04/30/2018
| Address |
784 Memorial Drive
Cambridge Massachusetts 02139
United States
|
|
Employees
|
- |
| Website |
http://www.infi.com |
| Updated |
07/08/2019 |
| Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA. |
